Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Revenue	$ 770,505	$ 768,051
Salaries, wages and benefits (including equity-based compensation expense of $8,677 and $8,678, respectively)	445,271	417,523
Professional fees	45,707	45,688
Supplies	28,342	26,652
Rents and leases	11,656	11,863
Other operating expenses	114,002	101,073
Depreciation and amortization	47,032	36,347
Interest expense, net	29,182	27,214
Debt extinguishment costs	1,269
Legal settlements expense	3,504
Transaction, legal and other costs	31,072	2,847
Total expenses	757,037	669,207
Income before income taxes	13,468	98,844
Provision for income taxes	4,404	20,074
Net income	9,064	78,770
Net income attributable to noncontrolling interests	(690)	(2,387)
Net income attributable to Acadia Healthcare Company, Inc.	$ 8,374	$ 76,383
Earnings per share attributable to Acadia Healthcare Company, Inc. stockholders:
Basic	$ 0.09	$ 0.84
Diluted	$ 0.09	$ 0.83
Weighted-average shares outstanding:
Basic	91,654	91,363
Diluted	92,038	92,010

This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 25
-Paragraph 23
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479405/805-10-25-23